Lineage, Inc. Common Stock (LINE)vsRafael Holdings, Inc. (RFL)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
RFL
Rafael Holdings, Inc.
$1.55
+11.51%
REAL ESTATE · Cap: $92.58M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 460777% more annual revenue ($5.36B vs $1.16M). RFL leads profitability with a 0.0% profit margin vs -2.7%. LINE earns a higher WallStSmart Score of 34/100 (F).
LINE
Avoid34
out of 100
Grade: F
RFL
Avoid30
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+54.5%
Fair Value
$2.64
Current Price
$1.55
$1.09 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 174.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RFL
The strongest argument for RFL centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 174.0% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : RFL
The primary concerns for RFL are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RFL is a hypergrowth play — different risk/reward profiles.
RFL is growing revenue faster at 174.0% — sustainability is the question.
RFL generates stronger free cash flow (-8M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (34/100 vs 30/100). RFL offers better value entry with a 54.5% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Rafael Holdings, Inc.
REAL ESTATE · REAL ESTATE SERVICES · USA
Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?